GlassScriptPhysician profile
Perveen Chattha
NPI 1215385653
$694.31
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $84.23 · 2020: $137 · 2021: $266 · 2022: $19.37 · 2023: $69.07 · 2024: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $188.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $187.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $233.43 | 2021-2024 | Ubrelvy, Botox, Qulipta |
| Merck Sharp & Dohme LLC | $108.69 | 2020-2021 | |
| Genzyme Corporation | $84.23 | 2019 | |
| Eisai INC. | $62.01 | 2020-2021 | |
| Lundbeck LLC | $46.30 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $45.85 | 2020 | |
| Biohaven Pharmaceuticals, INC. | $42.93 | 2021 | |
| Lilly USA, LLC | $38.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $32.87 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Perveen Chattha listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.